Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Backfill Bayesian Ordered Lattice Design for Phase I Clinical Trials.

medRxiv : the preprint server for health sciences·2026
Same author

Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC.

JTO clinical and research reports·2026
Same author

Bayesian Ordered Lattice Design for Phase I Clinical Trials.

Statistics in medicine·2026
Same author

Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US Veterans.

Parkinsonism & related disorders·2026
Same author

CDS-PD: a novel clinical decision support platform for Parkinson's disease.

Scientific reports·2026
Same author

MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype.

The Journal of clinical investigation·2025
Same journal

Mind the gender gap: how defining head trauma increases reporting in women aged 30-50.

Frontiers in neurology·2026
Same journal

Traditional Chinese medicine interventions for post-stroke cognitive impairment: an evidence mapping.

Frontiers in neurology·2026
Same journal

Acupuncture is independently associated with improved recovery in Guillain-Barré syndrome: a prospective observational study.

Frontiers in neurology·2026
Same journal

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders.

Frontiers in neurology·2026
Same journal

Lumbar puncture opening pressure, brain network hub integrity, and delirium in herpes simplex virus encephalitis: a prospective cohort study.

Frontiers in neurology·2026
Same journal

Sleep deprivation: a comprehensive review of multisystem impacts, underlying mechanisms, and emerging interventions.

Frontiers in neurology·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K

Associating Cognition With Amyloid Status Using Partially Ordered Set Analysis.

Sarah J A Carr1,2, Judith Jaeger3,4, Shijia Bian5

  • 1Department of Neurology, Case Western Reserve University, Cleveland, OH, United States.

Frontiers in Neurology
|October 2, 2019
PubMed
Summary
This summary is machine-generated.

Brain amyloid-beta positivity is linked to cognitive decline, particularly in episodic memory, with age influencing the association. This study used advanced models to predict amyloid status using cognitive tests and genetic factors.

Keywords:
ADNI/AIBLAlzheimer's diseaseamyloidcognitive impairmentpartially ordered sets

More Related Videos

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.3K

Related Experiment Videos

Last Updated: Jan 6, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.3K

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Biomarker Research

Background:

  • Brain amyloid-beta positivity is a known risk factor for cognitive impairment and dementia.
  • The precise cognitive functions most affected by amyloid-beta accumulation remain unclear.
  • Neuropsychological tests often engage multiple cognitive domains, complicating direct associations.

Purpose of the Study:

  • To investigate the association between specific cognitive functions and brain amyloid-beta positivity.
  • To explore these associations across different age groups in cognitively normal and MCI subjects.
  • To identify cognitive and demographic predictors of amyloid-beta positivity.

Main Methods:

  • Utilized partially ordered set (POSET) models to classify detailed cognitive profiles from ADNI2 and AIBL datasets.
  • Assessed episodic memory, cognitive flexibility, verbal fluency, attention, and perceptual-motor speed.
  • Employed random forest analysis, stratified by age, to predict amyloid positivity using cognitive, demographic, and APOE4 data.

Main Results:

  • Episodic memory and attention differences linked to amyloid positivity were observed in younger age groups (<70 and 70-80 years) in ADNI2.
  • Episodic memory differences were found in the 70-80 years group in the AIBL study; no cognitive differences were noted in the oldest group (81-90 years).
  • Random forest models highlighted intermediate episodic memory, delayed recall, and APOE4 allele count as key predictors of amyloid positivity, with age-dependent variable importance.

Conclusions:

  • The relationship between cognitive abilities and brain amyloid-beta positivity is age-dependent.
  • Episodic memory consistently emerged as the most significant cognitive predictor of amyloid-beta positivity across studies.
  • Cognitive testing, APOE4 genotyping, and demographic data effectively predict brain amyloid-beta presence.